DAIDS Safety Workshop: Part III Expedited Reporting via DAERS Albert Yoyin, M.D. and Archita Chatterjee, M.S. DAIDS RSC Safety Office Johannesburg, South.
Adverse Event Reporting Guidelines - Cancer Therapy Evaluation ...
Data management & statistics in clinical trials
Pharmacovigilance and ICH guidlines
This project has been funded in whole or in part with Federal funds from the Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases,
ICH E-5 Overview and Current Topics Mamoru Narukawa.
Expedited Reporting/DAERS May 13, 2011 Oluwadamilola Ogunyankin, M.D. Chinedum Abanobi, M.D. DAIDS Regulatory Support Center (RSC) Oluwadamilola Ogunyankin,
Sanjeev Miglani MD COO and Scientific Director CIDP Biotech India International Conference and CME workshop on Pharmacovigilance Systems and Rational Use.
Safety Workshop: Part II Expedited Reporting & Assessment Olu Ogunyankin, MD DAIDS Regulatory Support Center (RSC) Durban, South Africa May 13, 2011 Olu.
Manual v2.0 Changes and DAERS Lawrence Allan (HJF – DAIDS) Dr. Oluwadamilola Ogunyankin (RSC Safety Office) Lawrence Allan (HJF – DAIDS) Dr. Oluwadamilola.
Version 2 Expedited Reporting of Adverse Events to the DAIDS 1 Division of AIDS / NIAID.
